Paul Newby, PhD GSK

Paul has worked in the pharmaceutical industry in both research and manufacture roles for the past 24 years. He has been actively involved in introducing new rapid microbiological technologies, project management, microbiological method development and validation and microbiological support of nonsterile manufacture. Currently, he manages the Pharmaceutical Development UK microbiology teams within GSK Research & Development. Paul is a member of the BP expert committee on microbiology and has been involved in reviewing the draft EP chapter on Rapid Methods (5.1.4).  He is also part of the PDA technical working party charged with updating Technical Report 33 ‘Evaluation, Validation and Implementation of New Microbiological Testing Methods’ which was published in October 2013.